01 Approach to the Critical Patient /attcp 16
› Hemodynamic stability assessment
› Active vaginal bleeding
› Hypotension or tachycardia
› Signs of hypovolemic shock
› Sepsis risk stratification
› Fever or hypothermia
› Altered mental status
› Elevated lactate
› Obstetric emergency triggers
› Postpartum hemorrhage
› Suspected uterine infection
› Retained tissue with instability
Immediate Escalation Triggers
› Clinical deterioration
› Escalate to resuscitation bay
› Activate obstetrics and anesthesia
› Massive transfusion protocol if ongoing hemorrhage
02 History /hx 23
› Persistent vaginal bleeding
› Heavy bleeding beyond expected postpartum or post-abortion course
› Passage of tissue or clots
› Infectious symptoms
› Fever
› Chills
› Foul-smelling lochia
› Pelvic or lower abdominal pain
› Cramping
› Uterine tenderness sensation
Obstetric and Gynecologic Context
› Recent pregnancy outcome
› Vaginal delivery
› Cesarean delivery
› Spontaneous abortion
› Induced abortion
› Timing since delivery or procedure
› <24 hours
› 24-72 hours
› >72 hours
› Placental delivery details
› Manual extraction
› Placenta not intact
› Known accreta spectrum risk
05 Laboratory Tests /lt 10
Hematologic and Infectious Evaluation
› Complete blood count
› Hemoglobin trend for blood loss
› Leukocytosis for infection
› Serum lactate
› Tissue hypoperfusion marker
› Blood cultures
› Febrile or septic presentation
› Serum beta-hCG
› Persistent elevation post-pregnancy
› Decline failure after abortion
06 Diagnostic Tests /dt 18
› No validated scoring system specific to retained products
› Diagnosis based on clinical and imaging correlation
› Expert consensus approach
› Transvaginal ultrasound
› Endometrial thickness >10 mm
› Increased likelihood of retained tissue
› Echogenic intrauterine material
› Heterogeneous mass
› Doppler vascularity
› Increased flow suggesting retained placental tissue
› CT pelvis
› Reserved for unclear diagnosis
› Alternative causes of bleeding or infection
› Not first-line imaging
› MRI pelvis
› Suspected placenta accreta spectrum
› Equivocal ultrasound findings
› Preoperative planning
08 Treatment /t 21
› Uterotonic therapy
› Oxytocin infusion
› Continuous IV administration
› Titration based on uterine tone
› Misoprostol
› 600-800 micrograms per rectum or oral
› Antibiotic therapy
› Broad-spectrum coverage
› Ampicillin
› Gentamicin
› Clindamycin
› Indicated for suspected endometritis
› Uterine evacuation
› Dilation and curettage
› Vacuum aspiration
› Interventional radiology
› Uterine artery embolization
› Refractory bleeding
› Hysterectomy
› Life-threatening hemorrhage
› Failed conservative management
09 Special Populations /sp 10
› Placenta accreta spectrum risk
› Prior cesarean delivery
› Placenta previa
› Increased hemorrhage risk
› Early obstetric consultation
› Not applicable
› Condition limited to reproductive age
› Adolescents
› Higher risk after unsafe abortion
› Confidential care considerations
10 Background /b 21
› Incidence
› 1-3 percent of vaginal deliveries
› Higher after second-trimester loss
› Risk factors
› Placenta accreta
› Manual placental extraction
› Incomplete placental separation
› Persistent trophoblastic tissue
› Uterine subinvolution
› Ongoing bleeding
› Bacterial overgrowth
› Progression to endometritis or sepsis
Therapeutic Considerations
› Early recognition reduces morbidity
› Hemorrhage prevention
› Infection control
› Surgical evacuation definitive treatment
› Medical therapy adjunctive
› Multidisciplinary management
› Obstetrics
› Anesthesia
› Interventional radiology
11 Patient Discharge Instructions /pdi 6
Copy Discharge Instructions
Copy › Return to emergency department for heavy bleeding
› Soaking more than one pad per hour
› Return for fever or chills
› Temperature ≥38°C
› Return for worsening abdominal pain
› Follow-up with obstetrics within 24-72 hours
12 References /r 6
› Key sources
› American College of Obstetricians and Gynecologists Practice Bulletin on postpartum hemorrhage
› World Health Organization guidance on retained products of conception
› Key sources
› UpToDate review on retained products of conception
› Cochrane review on management of postpartum hemorrhage